These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 15239102)

  • 1. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway.
    Feldstein AE; Werneburg NW; Canbay A; Guicciardi ME; Bronk SF; Rydzewski R; Burgart LJ; Gores GJ
    Hepatology; 2004 Jul; 40(1):185-94. PubMed ID: 15239102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research of Herba Artemisiae Scoporiae inhibits the hepatic lipotoxicity].
    Chen S; Feng Q; Peng J; Xu L; Liu P; Liu C; Hu Y
    Zhongguo Zhong Yao Za Zhi; 2009 Sep; 34(18):2373-8. PubMed ID: 20030092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-alpha-mediated lysosomal permeabilization is FAN and caspase 8/Bid dependent.
    Werneburg N; Guicciardi ME; Yin XM; Gores GJ
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G436-43. PubMed ID: 15075251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha-associated lysosomal permeabilization is cathepsin B dependent.
    Werneburg NW; Guicciardi ME; Bronk SF; Gores GJ
    Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G947-56. PubMed ID: 12223355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of Qushi Huayu Decoction on cathepsin B and tumor necrosis factor-alpha expression in rats with non-alcoholic steatohepatitis].
    Zhang H; Feng Q; Li HS; Chen SD; Wang XN; Peng JH; Zhang N; Hu YY
    Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):928-33. PubMed ID: 18782536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of vascular smooth muscle cell to TNF-alpha-mediated death in the presence of palmitate.
    Rho MC; Ah Lee K; Mi Kim S; Sik Lee C; Jeong Jang M; Kook Kim Y; Sun Lee H; Hyun Choi Y; Yong Rhim B; Kim K
    Toxicol Appl Pharmacol; 2007 May; 220(3):311-9. PubMed ID: 17399759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin B inactivation attenuates hepatocyte apoptosis and liver damage in steatotic livers after cold ischemia-warm reperfusion injury.
    Baskin-Bey ES; Canbay A; Bronk SF; Werneburg N; Guicciardi ME; Nyberg SL; Gores GJ
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G396-402. PubMed ID: 15472011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
    Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
    Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator.
    Yu J; Ip E; Dela Peña A; Hou JY; Sesha J; Pera N; Hall P; Kirsch R; Leclercq I; Farrell GC
    Hepatology; 2006 Apr; 43(4):826-36. PubMed ID: 16557554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease.
    Diehl AM
    Clin Liver Dis; 2004 Aug; 8(3):619-38, x. PubMed ID: 15331067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
    Zhang L; Fang B
    Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of free fatty acid-induced hepatic lipotoxicity by 18beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways.
    Wu X; Zhang L; Gurley E; Studer E; Shang J; Wang T; Wang C; Yan M; Jiang Z; Hylemon PB; Sanyal AJ; Pandak WM; Zhou H
    Hepatology; 2008 Jun; 47(6):1905-15. PubMed ID: 18452148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization to the lysosomal cell death pathway upon immortalization and transformation.
    Fehrenbacher N; Gyrd-Hansen M; Poulsen B; Felbor U; Kallunki T; Boes M; Weber E; Leist M; Jäättelä M
    Cancer Res; 2004 Aug; 64(15):5301-10. PubMed ID: 15289336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An in vitro model applicable for fatty liver lipotoxicity pharmacological research].
    Hu YY; Zhang H; Chen SD; Feng Q; Lu X; Tan YZ
    Zhonghua Gan Zang Bing Za Zhi; 2008 Feb; 16(2):121-4. PubMed ID: 18304429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity.
    Li Z; Berk M; McIntyre TM; Gores GJ; Feldstein AE
    Hepatology; 2008 May; 47(5):1495-503. PubMed ID: 18220271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steatosis correlates with hepatic expression of death receptors and activation of nuclear factor-kappaB in chronic hepatitis C.
    Hung CH; Lee CM; Kuo FY; Jiang SR; Hu TH; Chen CH; Wang JH; Lu SN; Eng HL; Changchien CS
    Liver Int; 2008 Mar; 28(3):339-46. PubMed ID: 18290776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse regulation of NF-kappaB and peroxisome proliferator-activated receptors in murine nonalcoholic fatty liver.
    Romics L; Kodys K; Dolganiuc A; Graham L; Velayudham A; Mandrekar P; Szabo G
    Hepatology; 2004 Aug; 40(2):376-85. PubMed ID: 15368442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease.
    Hong F; Radaeva S; Pan HN; Tian Z; Veech R; Gao B
    Hepatology; 2004 Oct; 40(4):933-41. PubMed ID: 15382116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
    Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM
    J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning.
    Dawn B; Guo Y; Rezazadeh A; Wang OL; Stein AB; Hunt G; Varma J; Xuan YT; Wu WJ; Tan W; Zhu X; Bolli R
    J Mol Cell Cardiol; 2004 Jul; 37(1):51-61. PubMed ID: 15242735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.